MESO vs ONC
Mesoblast Limited · BeOne Medicines AG
Relative return (rebased to 100)
Key stats
| Metric | MESO | ONC |
|---|---|---|
| Price | $14.29 | $354.47 |
| Market Cap | $18.53B | $523.95B |
| P/E | — | 1826.04 |
| P/B | 32.25 | 101.27 |
| P/S | 1077.58 | 98.06 |
| ROE | -17.8% | 5.5% |
| Net Margin | -593.9% | 5.4% |
| Gross Margin | — | 87.5% |
| Revenue Growth | 191.4% | 40.2% |
| Dividend Yield | — | — |
| EPS | -$0.08 | $0.19 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.